Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Targeted histone deacetylase inhibition for cancer therapy.

Vigushin DM, Coombes RC.

Curr Cancer Drug Targets. 2004 Mar;4(2):205-18. Review.

PMID:
15032670
[PubMed - indexed for MEDLINE]
2.

Histone deacetylase inhibitors in cancer treatment.

Vigushin DM, Coombes RC.

Anticancer Drugs. 2002 Jan;13(1):1-13. Review.

PMID:
11914636
[PubMed - indexed for MEDLINE]
3.

Targeting epigenetic abnormalities with histone deacetylase inhibitors.

Conley BA, Wright JJ, Kummar S.

Cancer. 2006 Aug 15;107(4):832-40. Review.

PMID:
16826577
[PubMed - indexed for MEDLINE]
Free Article
4.

Histone deacetylation in epigenetics: an attractive target for anticancer therapy.

Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R, Simeoni S, Ragno R.

Med Res Rev. 2005 May;25(3):261-309. Review.

PMID:
15717297
[PubMed - indexed for MEDLINE]
5.

Histone deacetylase inhibitors as new cancer drugs.

Marks PA, Richon VM, Breslow R, Rifkind RA.

Curr Opin Oncol. 2001 Nov;13(6):477-83. Review.

PMID:
11673688
[PubMed - indexed for MEDLINE]
6.

Development of histone deacetylase inhibitors for cancer treatment.

Marchion D, Münster P.

Expert Rev Anticancer Ther. 2007 Apr;7(4):583-98. Review.

PMID:
17428177
[PubMed - indexed for MEDLINE]
7.

HDAC inhibitors for the treatment of cancer.

Secrist JP, Zhou X, Richon VM.

Curr Opin Investig Drugs. 2003 Dec;4(12):1422-7. Review.

PMID:
14763127
[PubMed - indexed for MEDLINE]
8.

Role of histone deacetylase inhibitors in the treatment of cancer (Review).

Mei S, Ho AD, Mahlknecht U.

Int J Oncol. 2004 Dec;25(6):1509-19. Review.

PMID:
15547685
[PubMed - indexed for MEDLINE]
9.

Histone deacetylase inhibitors: current status and overview of recent clinical trials.

Ma X, Ezzeldin HH, Diasio RB.

Drugs. 2009 Oct 1;69(14):1911-34. doi: 10.2165/11315680-000000000-00000. Review.

PMID:
19747008
[PubMed - indexed for MEDLINE]
10.

Histone deacetylase inhibitors in cancer therapy.

Rasheed WK, Johnstone RW, Prince HM.

Expert Opin Investig Drugs. 2007 May;16(5):659-78. Review.

PMID:
17461739
[PubMed - indexed for MEDLINE]
11.

Histone deacetylase inhibitors.

Marks PA, Richon VM, Miller T, Kelly WK.

Adv Cancer Res. 2004;91:137-68. Review.

PMID:
15327890
[PubMed - indexed for MEDLINE]
12.

The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation.

Karagiannis TC, El-Osta A.

Cell Cycle. 2006 Feb;5(3):288-95. Epub 2006 Feb 17. Review.

PMID:
16418577
[PubMed - indexed for MEDLINE]
Free Article
13.

Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.

Martínez-Iglesias O, Ruiz-Llorente L, Sánchez-Martínez R, García L, Zambrano A, Aranda A.

Clin Transl Oncol. 2008 Jul;10(7):395-8. Review.

PMID:
18628067
[PubMed - indexed for MEDLINE]
14.

Histone deacetylase inhibitors: anticancer compounds.

Smith KT, Workman JL.

Int J Biochem Cell Biol. 2009 Jan;41(1):21-5. doi: 10.1016/j.biocel.2008.09.008. Epub 2008 Sep 19. Review.

PMID:
18845268
[PubMed - indexed for MEDLINE]
15.

Histone deacetylase inhibitors: design, structure-activity relationships and therapeutic implications for cancer.

Marson CM.

Anticancer Agents Med Chem. 2009 Jul;9(6):661-92. Review.

PMID:
19601748
[PubMed - indexed for MEDLINE]
16.

Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents.

Garcia-Manero G, Issa JP.

Cancer Invest. 2005;23(7):635-42. Review.

PMID:
16305991
[PubMed - indexed for MEDLINE]
17.

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

Marks PA, Richon VM, Rifkind RA.

J Natl Cancer Inst. 2000 Aug 2;92(15):1210-6. Review.

PMID:
10922406
[PubMed - indexed for MEDLINE]
Free Article
18.

Acetylation of proteins as novel target for antitumor therapy: review article.

Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A.

Amino Acids. 2004 Jul;26(4):435-41. Epub 2004 Jun 11. Review.

PMID:
15290351
[PubMed - indexed for MEDLINE]
19.

Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.

Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG.

Expert Opin Investig Drugs. 2007 May;16(5):569-71. Review.

PMID:
17461732
[PubMed - indexed for MEDLINE]
20.

Histone deacetylase inhibitors: multifunctional anticancer agents.

Liu T, Kuljaca S, Tee A, Marshall GM.

Cancer Treat Rev. 2006 May;32(3):157-65. Epub 2006 Mar 3. Review.

PMID:
16516391
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk